| Application no. and date | 14001970.4 (espacenet) (Federated) (European Patent Register), 20051220 | | Patent/reg. no. and date | DK/EP 2805723, 20180117 | | Publication date | 20141126 | | Priority no. and date | EP 04106909, 20041222, US 638669 P, 20041222 | | EP pub. no. and date |
EP 2805723 20141126 | | Effective date | | | Applicant/owner | Merck Serono SA, Centre Industriel
1267 Coinsins, Vaud, CH | | Applicant ref. no. | P63454DK01 | | Inventor | LOPEZ-BRESNAHAN, Maria, 145 South Great Road
Lincoln, MA 01773, US,
De Luca, Giampiero, Chemin de Conches 15B
1231 Conches/GE, CH,
Ythier, Arnaud, Route de Vireloup 88
1239 Collex-Bossy Geneva, CH,
Munafo, Alain, Rue des Creuses 12
1182 Gilly, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/7076 (2006.01) , A61K 38/21 (2006.01) , A61K 9/20 (2006.01) , A61P 25/00 (2006.01) | | Title | Cladribin-regime til behandling af multipel sclerose | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
